Compare SES & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SES | BNTC |
|---|---|---|
| Founded | 2012 | 1995 |
| Country | United States | United States |
| Employees | N/A | 24 |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 384.1M | 396.3M |
| IPO Year | 2020 | 2020 |
| Metric | SES | BNTC |
|---|---|---|
| Price | $0.54 | $11.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $4.00 | ★ $27.67 |
| AVG Volume (30 Days) | ★ 16.3M | 118.5K |
| Earning Date | 04-23-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.03 | 6.67 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $21,000,000.00 | N/A |
| Revenue This Year | $53.90 | N/A |
| Revenue Next Year | $111.26 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 929.41 | N/A |
| 52 Week Low | $0.49 | $9.85 |
| 52 Week High | $3.73 | $16.76 |
| Indicator | SES | BNTC |
|---|---|---|
| Relative Strength Index (RSI) | 44.89 | 36.33 |
| Support Level | $0.50 | $10.04 |
| Resistance Level | $0.67 | $14.14 |
| Average True Range (ATR) | 0.05 | 0.65 |
| MACD | 0.01 | -0.17 |
| Stochastic Oscillator | 13.82 | 9.25 |
SES AI Corp is a developer and manufacturer of rechargeable battery technologies and battery materials for Energy Storage Systems (ESS), Urban Air Mobility (UAM), drones, robotics, electric vehicles (EVs), and other applications. For Enery Storage Systems, the company supplies hardware and software solutions with battery health and safety management software powered by its AI-based platform, Molecular Universe. Additionally, it offers battery materials and high-energy and power-density Li-Metal and Li-ion cells, which can be used for drones, UAM, robotics, and EV applications. The company also offers access to Molecular Universe as a software product. Currently, it generates maximum revenue from the development of Li-ion and Li-Metal battery materials as per the client's specifications.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.